Policy & Intel

Policy Intel & Events

The Latest from Roberti Global

Roberti Global insights on policy trends, political analysis, firm updates, and front-line perspectives from Washington.

All Events Firm Update Media PBM Tracker Policy Intel

Firm UpdatePBM TrackerPolicy & Event UpdatesPolicy Intel

January 7, 2026

Monthly PBM Reform Report – December 2025

Monthly PBM Reform Report – December 2025 PDF: PBM & Pharmacy Related Legislative Tracker Legislative Activity Legislation In December, the House narrowly advanced a Republican-led health care package that combined small-business insurance reforms with a broad set of pharmacy benefit manager (PBM) transparency provisions. On December 17, the

Media

August 30, 2025

Eisai-Developed Treatment for Alzheimer’s Disease Approved by FDA

Eisai Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for once weekly lecanemab-irmb subcutaneous injection (U.S. brand name: LEQEMBI® IQLIKTM) for maintenance dosing. LEQEMBI IQLIK is a subcutaneous autoinjector (SC-AI) developed by Eisai, containing 360 mg/1.8 mL (200 mg/mL)

Firm UpdatePolicy & Event Updates

January 7, 2026

Roberti Global’s Director of Operations Nominated for 2025 DGA Awards

Photo: The Season One Assistant Director team of HBO’s The Pitt pictured outside Stage 21 on the Warner Brothers studio lot in Burbank, California. Roberti Global’s Director of Operations, Chloe Huckins, is a member of the Directors Guild of America and previously worked in the Los Angeles television industry over

Events

January 30, 2026

Samsung Gala’s Historic Attendance Elevates Korean Cultural Legacy

Samsung Electronics Co., Ltd., in partnership with the Smithsonian’s National Museum of Asian Art, hosted a gala event on Jan. 28 at the Arts and Industries Building in Washington D.C. to commemorate the success of the “Korean Treasures: Collected, Cherished, Shared” exhibition, the first U.S. showcase of masterpieces from the